Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder
2007-003891-20Phase 4Completed
- Sponsor
- Pro Persona
- Start
- Nov 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in post-traumatic stress disorder (PTSD) comparing D-cycloserine + exposure therapy with Placebo + exposure therapy (2 arms). Primary endpoint: PTSD symptoms. Started Nov 2007; status: completed.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2007-003891-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003891-20.